Owner: Director of Quality
Class: Planning Document (Class 4)
Status: Active
Last Updated: 2026-10-15
Cycle: 2026-10-12__release-v9.12

---

# Delivery Verification Report — 2026-10-12__release-v9.12

## §1 — Verification Status

```
Status: Verified_with_deviations
Sprint goal: Restore AI journal summaries for UUID trade IDs (BLG-BE-162, P1); make signal sizing, stops and position status correct across Signals, Positions and Risk; and let Trade Entry show the stop, risk and size before save. Also ship v9.12's accessibility, security, operations, spec and governance hygiene items.
Cycle: 2026-10-12__release-v9.12
Backlog slice source: claude/cycles/2026-10-12__release-v9.12/stage4_backlog_slice.md (read with stage4_backlog_slice_addendum.md)
Verification run: 2026-10-15T14:04:55Z
```

**Mode:** `standard`.

**Preflight (STEP -1):**

| Check | Result |
|-------|--------|
| Branch | `main` (at `8ef00e33`, after the sprint-close commit `194bbc76`) |
| Lifecycle guard | `status = Sprint_Complete` |
| `execution_state.json` | `sealed = true`; `merge_gate.all_merged = true` (6/6 EPICs) |
| Backlog slice | `amended_backlog_slice_path` is empty, so `stage4_backlog_slice.md` is authoritative. It matches `execution_state.json.backlog_slice_source`, which also names the sealed addendum (ST-10, ST-22–ST-24) |
| Readiness statement | `sprint_close.md`: all three fields `Yes` |
| QA evidence logs | Present for all 6 merged EPICs, all signed and dated (see §3) |
| PR numbers | Non-null for all 6 EPICs (#2022–#2027), all `merged`, so no recovery was needed |
| Required inputs | All present. Legacy shared-file cycle, with no `execution_state/` directory |

**Why `Verified_with_deviations`:**
- There are no P0, P1 or P2 deviations, no QA `Fail` results and no traceability gaps.
- Three stories are `Pass_with_deviation` at the STEP 2.1 P3 default (ST-06, ST-28, ST-34). Each AC gap is disclosed and has a tracking record (see §4). None is a found pre-existing defect filed above P3, so the found-defect severity rule (LL-v9.11-P4-01) does not raise any of them.
- Under §7, P3 deviations are recorded and verification proceeds as `Verified_with_deviations`. No PO + DoQ acceptance record is required.

---

## §2 — Traceability Matrix

| ST Item | Title | Outcome | Spec Reference | Backlog Entry |
|---------|-------|---------|---------------|---------------|
| ST-01 | Accept UUID trade IDs in the journal summary, end to end | merged | `data_model.md#DS-31`; `ai_endpoints.md#POST /ai/journal-summary`; `ai_endpoints.md#GET /ai/journal-summary/history`; `test_journal_summary_uuid_trade_ids.py` | N/A |
| ST-02 | Drop briefing actions that name a ticker outside the context | merged | `ai_endpoints.md#POST /ai/daily-briefing`; `test_briefing_actions_and_cash_context.py`; `ai_prompt_template_golden_fixtures.json` | N/A |
| ST-03 | Label available cash and starting capital separately in the briefing context | merged | `ai_endpoints.md#POST /ai/daily-briefing`; `test_briefing_actions_and_cash_context.py`; `ai_prompt_template_golden_fixtures.json` | N/A |
| ST-04 | Check that briefing and chat responses citing a stop include its recalculation time | merged | `ai_endpoints.md#POST /ai/daily-briefing`; `ai_endpoints.md#POST /ai/chat`; `run_ai_output_boundary_sample_audit.py`; `test_ai_stop_time_check.py` | N/A |
| ST-05 | Widen the monthly P&L narrative's instrument-directive scan to inflected and indirect wording | merged | `ai_s13_boundary_test_suite.md#Scenario B-MPN-04`; `test_monthly_pnl_narrative.py` | N/A |
| ST-06 | Make the daily AI cost alert count Claude calls | merged | `ai_endpoints.md#POST /ai/check-daily-cost`; `ai-daily-cost-check.yml`; `ai_monthly_pnl_narrative_cost_estimate_2026-10-08.md`; `test_daily_cost_counts_claude_calls.py`; `test_journal_summary_claude_audit.py` | N/A |
| ST-07 | Give zero-ATR signals no allocation in batch sizing | merged | `signal_endpoints.md#Field notes`; `test_signal_sizing.py`; `test_nightly_computations.py` | N/A |
| ST-08 | Include entry fees in batch signal total cost | merged | `signal_endpoints.md#Field notes`; `test_signal_sizing.py` | N/A |
| ST-09 | Assert the §4.1.5 FX defaulting/echo and §4.1.6 insufficient-cash sizing results in CI | merged | `test_sizing_fx_and_cash.py`; `strategy_rule_test_traceability_matrix.md` | N/A |
| ST-10 | Make the Trail Stop action work against a real route, or remove it; stop ignoring a supplied entry stop | merged | `positions.md#Trail Stop Action`; `portfolio_endpoints.md#POST /portfolio/position`; `epic01-v34-lifecycle.spec.js`; `test_add_position_stop_handling.py` | N/A |
| ST-11 | Never let 2-dp rounding lower a stored stop | merged | `strategy_rules.md#7.3 Stop movement rule (hard constraint)`; `test_strategy_parameter_parity.py` | N/A |
| ST-12 | Recompute US positions with a NULL fill_price without error, and add US parity cases | merged | `data_model_positions_dictionary.md#5. Key Derivation Rules`; `test_strategy_parameter_parity.py`; `test_atr_provenance.py` | N/A |
| ST-13 | Decide Risk page LOSING/PROFITABLE on native P&L, matching the lifecycle badge | merged | `position_endpoints.md#GET /positions`; `portfolio_endpoints.md#GET /portfolio`; `risk_dashboard.md#6.3 State Badges`; `test_display_status_native_basis.py` | N/A |
| ST-14 | Use the US exchange calendar for the gap-risk "next trading session" | merged | `decisions--2026-09-30__release-v9.9--gap-risk-flag-section13-review.md#Addendum`; `position_endpoints.md#GET /positions/{position_id}/gap-risk`; `us_market_calendar.py`; `test_gap_risk.py` | N/A |
| ST-15 | Show the user when a position's stop is frozen for lack of ATR | merged | `positions.md#Frozen Stop Indicator`; `position_endpoints.md#GET /positions`; `data_model.md#DS-32`; `stop-cell-provenance.spec.js`; `test_atr_provenance.py` | N/A |
| ST-16 | Keep first-time Settings saves from writing NULL strategy columns; snapshot §11 values on trade plans | merged | `settings_endpoints.md#POST /settings`; `si02_data_schema.md#effective_settings_snapshot (Gap 4)`; `test_settings_create_and_plan_snapshot.py` | N/A |
| ST-17 | Add an ATR preview endpoint so Trade Entry shows the stop, risk and size before save | merged | `position_form.md#ATR (14-day)`; `position_form.md#Initial Stop (set by system)`; `market_endpoints.md#GET /market/atr/{ticker}`; `test_market_atr_preview_endpoint.py`; `trade-entry-atr-preview.spec.js` | N/A |
| ST-18 | Show the currency unit on Trade Entry's ATR field and reject implausible typed ATRs | merged | `position_form.md#ATR (14-day)`; `position_form.md#Validation Errors`; `portfolio_endpoints.md#POST /portfolio/position`; `test_add_position_stop_handling.py`; `trade-entry-atr-unit-validation.spec.js` | N/A |
| ST-19 | Cover the §4.1.7 sizing-widget behaviours with Playwright | merged | `position-sizing-widget-behaviours.spec.js`; `strategy_rule_test_traceability_matrix.md`; `strategy_rules.md#4.1.7 User interface interaction requirement` | N/A |
| ST-20 | Correct the Settings helper text for the fixed strategy parameters | merged | `settings.md#Settings Groups & Fields`; `settings-strategy-parameters-fixed.spec.js` | N/A |
| ST-21 | Strategy-copy conformance: a frontend constants module, a CI lint for UI text restating §5–§11, and a named owner | merged | `strategy.js`; `check_strategy_copy.py`; `frontend_specs_ux_documentation_owner.md`; `test_check_strategy_copy.py`; `test_strategy_parameter_parity.py` | N/A |
| ST-22 | Link each Grace Period row to its position, and align the panel's text and date format with the spec | merged | `risk_dashboard.md#5.2 Display`; `positions.md#Position Deep Link`; `grace-panel-position-link.spec.js` | N/A |
| ST-23 | Make the Reports and Notifications pages pass WCAG colour contrast in the light theme | merged | `design_system.md#Light-Theme Colour Tokens`; `design_system.md#6. Dark and Light Themes`; `accessibility-axe-scan.spec.js` | N/A |
| ST-24 | Move white-on-amber-600 badges to a passing contrast outside Replay | merged | `positions.md#Gap Risk Badge`; `strategy_benchmark.md`; `trade_plan.md`; `dashboard.md`; `strategy-benchmark.spec.js`; `gap-risk-flag.spec.js` | N/A |
| ST-25 | Stop the post-grace stop-health monitor alerting on the morning a position's grace ends | merged | `check_post_grace_stop_health.py`; `test_post_grace_stop_health.py` | N/A |
| ST-26 | Audit trail for strategy-parameter changes in Settings | merged | `data_model.md#DS-33`; `settings_endpoints.md#GET /settings`; `settings.md#Last Change Line`; `test_settings_change_log.py`; `settings-last-change.spec.js` | N/A |
| ST-27 | Re-assess the bundled `REACT_APP_API_KEY` against its actual write scope | merged | `credential_policy.md` | N/A |
| ST-28 | Apply the in-range dependency patch/minor bumps from the October 2026 quarterly review | merged | `dependency_update_review_2026-10-06.md`; `requirements.txt`; `package.json` | N/A |
| ST-29 | Find out why a staging-deploy.yml hook deploy of a governance-only commit never went live | merged | `staging_deploy_notes.md`; `staging-deploy.yml`; `wait_for_staging_deploy_live.py` | N/A |
| ST-30 | Live-fire the stale-staging check from main against a deliberate divergence | merged | `staging_smoke_test.py`; `staging-smoke-test.yml` | N/A |
| ST-31 | Add requirements-dev.txt to the local backend setup instructions | merged | `README.md`; `quarterly_dependency_upgrade_cadence_policy.md` | N/A |
| ST-32 | Inventory the scheduled GitHub workflows: owner, cron, tables written, monthly minutes | merged | `scheduled_workflows_inventory.md` | N/A |
| ST-33 | Reconcile DELETE /trade-plans/{id}'s success envelope with conventions.md §12 | merged | `conventions.md#12.1 Named exceptions`; `trade_plan_endpoints.md#DELETE /trade-plans/{id}`; `test_api_contracts.py` | N/A |
| ST-34 | Triage the drift detector's new live-vs-doc findings | merged | `data_model.md#Drift Detector Triage (2026-10-13, v2.60)`; `data_model.md#DS-17`; `check_data_model_drift.py` | N/A |
| ST-35 | Name the Gap Risk Badge's real data source in positions.md | merged | `positions.md#Gap Risk Badge`; `ux_spec.md#9. API Dependency` | N/A |
| ST-36 | Replace positions.stop_price with current_stop in the action-rate spec and docstring | merged | `metrics_definitions.md#Trailing Stop Action Rate`; `data_model.md#DS-24` | N/A |
| ST-37 | Refresh the Gap Risk Flag §13 decision record to match strategy_rules.md v1.14 | merged | `decisions--2026-09-30__release-v9.9--gap-risk-flag-section13-review.md`; `strategy_rules.md#13.3 Design boundary rationale` | N/A |
| ST-38 | Settle positions.entry_price's currency in the specs | merged | `data_model.md#2. Positions Table`; `data_model_positions_dictionary.md#5. Key Derivation Rules`; `data_model.md#DS-23` | N/A |
| ST-39 | Check backlog item integrity after every cross-EPIC merge resolution | merged | `CLAUDE.md#8. Cross-EPIC Merge Conflict Resolution`; `check_backlog_item_integrity.py`; `test_check_backlog_item_integrity.py`; `backlog-item-integrity.yml` | N/A |
| ST-40 | Report gated items whose gating backlog item has shipped, and read that list in Release Planning §1.3a | merged | `release_planning_prompt.md#1.3a Gate-Detection Procedure (Mandatory, Scripted)`; `scan_backlog_gate_conditions.py`; `test_scan_backlog_gate_conditions_gating_item_shipped.py` | N/A |
| ST-41 | Script the execution_state.json read-back check from execution_prompt.md §9.2 | merged | `execution_prompt.md#9.2 State Update Rule (Hard Requirement)`; `check_execution_state_consistency.py`; `test_check_execution_state_consistency.py` | N/A |
| ST-42 | Name one Skill-Silo aggregation method in roadmap_prompt.md §7.1 | merged | `roadmap_prompt.md#7.1 Skill-Silo Alert`; `compute_rebalance_diagnostics.py`; `test_compute_rebalance_diagnostics.py` | N/A |
| ST-43 | Rule on reduced-roster idea-intake windows, and cap them if permitted | merged | `idea_intake_prompt.md#4.1 Reduced-Roster Windows`; `roadmap_prompt.md#STEP -1.6` | N/A |
| ST-44 | Add a split-credit secondary tally to compute_role_share_history.py | merged | `compute_role_share_history.py`; `role_share_history.md#History (one row per cycle`; `test_compute_role_share_history.py` | N/A |
| ST-45 | Add unit tests for compute_role_share_history.py and a STEP 7.1 pin | merged | `compute_role_share_history.py`; `test_compute_role_share_history.py`; `test_compute_rebalance_diagnostics.py` | N/A |
| ST-46 | Scope utils.* test stubs so a reordered run passes | merged | `_scoped_utils_stubs.py`; `conftest.py`; `test_utils_stub_leak_guard.py` | N/A |
| ST-47 | Guard the positions.fees_paid NOT NULL invariant in the entry flow and SQL seeds | merged | `data_model.md#DS-23`; `test_fees_paid_not_null_invariant.py` | N/A |
| ST-48 | Remove the leaked sandbox /tmp path from backend/setup.cfg | merged | `setup.cfg` | N/A |

`Traceability gaps: 0 | Items returned: 0 | Backlog entries added this run: 0`

All 48 slice items have a `merged` record in `execution_state.json` with `acceptance_verified = true`, `deviations_filed = true` and non-empty `spec_references`. No story needed the `spec_reference_not_applicable` exemption. Anchors above are shortened; `execution_state.json` holds the full strings, and sprint close's path-existence check (`LL-v9.10-P4-01`, `execution_prompt.md` STEP 5.1) confirmed every path resolves on disk.

---

## §3 — QA Evidence Summary

| EPIC | Items | Pass | Fail | Sign-off | Notes |
|------|-------|------|------|----------|-------|
| EPIC-01 | 6 | 5 Pass + 1 Pass_with_deviation (ST-06) | 0 | ✓ Sprint Execution Engine (agent-mediated, Director of Quality role — §5.3), 2026-10-13 | First pass Blocked (journal summary wrote no `claude_audit_log` row), fixed in `4bb38bdd`; second pass Approved. Full backend suite 2465 passed |
| EPIC-02 | 10 | 9 Pass + 1 Pass with notes (ST-12) | 0 | ✓ Sprint Execution Engine (agent-mediated, Director of Quality role — §5.3), 2026-10-13 | CI Pytest Suite green at `47a24a3d` (run 38444759145); Playwright 25/25 on the two changed specs |
| EPIC-03 | 8 | 8 | 0 | ✓ Sprint Execution Engine (agent-mediated, Director of Quality role — §5.3), 2026-10-15 | First pass Blocked on two findings; retry Approved. Every observable UI AC has Playwright coverage. Backend 2647 passed |
| EPIC-04 | 8 | 5 Pass + 2 Pass with notes (ST-26, ST-31) + 1 Pass_with_deviation (ST-28) | 0 | ✓ Sprint Execution Engine (agent-mediated, Director of Quality role — §5.3), 2026-10-15 | Reaffirmed after the ST-28 numpy correction. CI Pytest on Python 3.11 green at `2fb6f888` (run 38725364575) |
| EPIC-05 | 6 | 5 Pass + 1 Pass_with_deviation (ST-34) | 0 | ✓ Sprint Execution Engine (agent-mediated, Director of Quality role — §5.3), 2026-10-13 | Spec/doc EPIC; ST-34–ST-38 by manual acceptance review |
| EPIC-06 | 10 | 10 | 0 | ✓ Sprint Execution Engine (agent-mediated, Director of Quality role — §5.3), 2026-10-13 | Full backend suite passes in both default and reversed file order (2540 passed each) |

**Total: 48/48 items, 0 Fail results.**

**Tier 2 check:** every signer uses the recognised agent-mediated format, naming the Director of Quality role and §5.3. No counter-sign is needed.

**STEP 2.3 sign-off completeness** is confirmed for all 6 EPICs:
- All checkboxes are marked, including the conditional Strategy-values line.
- All dates are non-blank.
- Every `Pass with notes` and `Pass_with_deviation` row has a substantive comment:
  - **ST-06:** names the AC 2 remainder (live run record due post-merge) and cites the Product Owner ruling in `ESC-EXEC-20261013-02`. The remainder closed on 2026-10-13 (run 38374258055, `DEL-20261013-02`). This engine confirmed `ESC-EXEC-20261013-02` exists in `execution_escalations.md` and is mirrored as `Resolved`. No remainder is left to track.
  - **ST-28:** names the AC 1 narrowing (7 of 8 backend bumps; `numpy` held at 2.4.6) and `BLG-TECH-24`.
  - **ST-34:** names the AC 1 partial (3 of finding 5's original 11 names cannot be named individually) and `BLG-QA-223`, whose scope was extended to keep each detector run's `--json` output.
  - **ST-12, ST-26, ST-31:** all ACs met; notes on intent (ST-12, follow-up `BLG-BE-175`), the RLS-role check (ST-26) and an incidental finding (ST-31, `BLG-QA-225`).

**Acceptance-criteria cross-reference (STEP 2.2).** No criterion was narrowed or omitted without disclosure. The disclosed narrowings:
- **ST-06 (`Pass_with_deviation`), AC 2.** The live cost-alert run record was accepted by the Product Owner as due post-merge, and closed post-merge before sprint close.
- **ST-28 (`Pass_with_deviation`), AC 1.** `numpy` 2.5.3 requires Python 3.12 and the backend is pinned to 3.11.0. It was reverted to 2.4.6. The other 7 backend and all 20 frontend bumps landed at the reviewed versions.
- **ST-34 (`Pass_with_deviation`), AC 1.** Every name was checked, but the v9.9 detector run kept no output, so 3 of finding 5's 11 names cannot be recorded individually. AC 2 is met.

---

## §4 — Deviation Register

`sprint_close.md`'s "Deviations Filed This Sprint" lists **no new canonical-spec `DEV-*` records**. Every story's deviation check finished with `deviations_filed = true`.

The table records the three QA-evidence `Pass_with_deviation` results.

| Deviation Ref | ST Item | Priority | Description | Disposition | Backlog Item |
|---------------|---------|----------|-------------|-------------|-------------|
| — (QA evidence only) | ST-06 / EPIC-01 | P3 (default) | AC 2's live run record was due post-merge; closed 2026-10-13 (run 38374258055) | Recorded. No remainder: closed under the Product Owner ruling in `ESC-EXEC-20261013-02`. Exempt from Known Deviations sync: shipped behaviour matches `ai_endpoints.md#POST /ai/check-daily-cost` | — (closed; `ESC-EXEC-20261013-02`, `DEL-20261013-02`) |
| — (QA evidence only) | ST-28 / EPIC-04 | P3 (default) | AC 1 narrowed: 7 of 8 backend bumps; `numpy` held at 2.4.6 because 2.5.3 needs Python 3.12 | Recorded. Exempt from Known Deviations sync: the cited source is a dependency review record (`dependency_update_review_2026-10-06.md`), not a product spec, so the backlog item is the equivalent evidence (`ESC-CLOSE-20260923-02` extension of `LL-v9.1-P4-01`). `BLG-TECH-24`'s scope records the hold in the next quarterly review | `BLG-TECH-24` (P3, confirmed) |
| — (QA evidence only) | ST-34 / EPIC-05 | P3 (default) | AC 1 partly met: 3 of finding 5's original 11 names cannot be named, because the v9.9 detector run kept no output | Recorded. Exempt from Known Deviations sync: an evidence gap in the triage, not a divergence from `data_model.md` | `BLG-QA-223` (confirmed; filed at **P4**, see note) |

**Hard blocks:** none. There are no P0, P1 or P2 items, so no acceptance records are required.

**Priority note (observation, not a block):** `sprint_close.md` lists `BLG-QA-223` at P3, but its `backlog.md` entry says `P4 (Trivial)`. The QA-evidence deviation itself takes the P3 default; the tracking item's own priority is lower. This run does not change the backlog item's priority (append-only scope). Routed to the Phase 4 lessons learnt and for the item owner's review.

**Known Deviations sync (v3.13 scope):** not triggered. The sprint-close register is empty, and no `Pass_with_deviation` comment shows shipped behaviour contradicting its cited spec.

---

## §5 — Outstanding Items and Deferred Execution Blockers

### (a) Outstanding items carried to backlog

`sprint_close.md` states "Items Delegated and Outstanding: None outstanding" and "Open Escalations: None open at sprint close". `execution_state.json` has empty `blocked_items`, `delegated_items` and `open_escalations`, and every `ESC-EXEC-2026101*` entry in `.claude_current_state.json.open_escalations` is `Resolved`. No item needs a new backlog entry. All 45 backlog follow-ups listed in `sprint_close.md` were confirmed present in `backlog.md`, and `scripts/check_backlog_item_integrity.py` passes.

| Item | Type | Outcome | Backlog ref |
|------|------|---------|-------------|
| DEL-20261013-01 (ST-01) | delegated (DS-31 migration, staging run) | Unblocked; applied to staging and production; UUID journal summary returned content on staging | — |
| DEL-20261013-02 (ST-06) | delegated (cost-alert live run) | Unblocked post-merge 2026-10-13; run 38374258055 succeeded | — |
| DEL-20261013-03 (ST-34) | delegated (production index read) | Unblocked; `pg_indexes` confirmed DS-17's index | `BLG-SPEC-197` (staging) |
| DEL-20261013-04 (ST-15) | delegated (DS-32 migration) | Unblocked; applied and verified on staging and production | — |
| DEL-20261015-01 (ST-26) | delegated (DS-33 migration) | Unblocked; applied with RLS on staging and production | — |
| DEL-20261015-02 (ST-29) | delegated (Render dashboard read) | Unblocked; cause was the staging frontend's branch setting | `BLG-OPS-189` |
| DEL-20261015-03 (ST-30) | delegated (stale-staging live fire) | Unblocked; failing run 38722585429, passing run 38723949916 | — |
| DEL-20261015-04 (ST-28) | delegated (staging check of bumps) | Unblocked; AAPL/US and VOD/UK ATRs `status: ok` at `2fb6f888` | `BLG-TECH-24` |
| ESC-EXEC-20261013-01..08, ESC-EXEC-20261015-01 | escalations | All 9 resolved within SLA; -15-01 a human Product Owner accept-risk decision (ST-27) | — |

### (b) Deferred execution blocker dispositions

`claude/cycles/2026-10-12__release-v9.12/state.json.deferred_execution_blockers = []`. There are no deferred execution blockers to disposition.

### Stale Parked Items (STEP 4.3)

Skipped, because `stage4_backlog_slice.md` has no items with `status = parked`.

---

## §6 — Test Coverage Assessment

| EPIC | test_scenarios | Cross-reference result |
|------|------------------|--------------------------|
| EPIC-01 | 13 files | All named as run in `qa_evidence_EPIC-01.md`; full backend suite 2465 passed at `4bb38bdd`, reproduced by the review |
| EPIC-02 | 12 files | All named as run; CI Pytest Suite green at `47a24a3d`; Playwright 25/25 on the two changed specs |
| EPIC-03 | 20 files | All named as run against a production build; local-only timing failures pass in CI; backend 2647 passed |
| EPIC-04 | 3 files | All named as run; full Playwright shards (run 38704880394) and CI Pytest on Python 3.11 (run 38725364575) green |
| EPIC-05 | 1 file | Named as run (ST-33 DELETE cases, 2 passed), plus 80 drift tests as regression. ST-34–ST-38 by manual acceptance review |
| EPIC-06 | 7 files | All named as run; full suite passes in default and reversed order (2540 each) |

All 56 referenced files exist on disk.

**Algorithm replacement advisory (AUD-2026-06-22-007):**
- **ST-07** changes batch sizing so zero-ATR signals take no allocation; **ST-11** adds `stop_to_store()` on both recompute paths; **ST-12** adds `native_entry_price()`; **ST-13** moves `classify_position()` to the native P&L basis; **ST-14** replaces the gap-risk "next trading session" with a rule-based NYSE calendar.
  - None retires a prior scenario file. The prior domain-level files (`test_nightly_computations.py`, `test_strategy_parameter_parity.py`, `test_gap_risk.py`, `test_atr_provenance.py`, `tests/e2e/epic01-v34-lifecycle.spec.js`) are in EPIC-02's `test_scenarios` and were re-run, alongside the new purpose-built tests.

**EPIC-05 manual review:** ST-34–ST-38 are spec, decision-record and docstring corrections with no runtime or UI behaviour. Manual acceptance review is the correct method, so no scenario gap arises.

The cycle's own reviews found test-coverage weaknesses, and each already has a backlog item (`BLG-QA-221`, `BLG-QA-222`, `BLG-QA-224`, `BLG-QA-226`). No new gaps were found by this run, and no duplicate items were added.

### Test Scenario Gaps — Structured Register

| gap_id | EPIC | Description | Qualifying reason | Disposition |
|--------|------|-------------|-------------------|-------------|
| TSG-v9.12-01 | EPIC-01 | The `ai_audit_log` UUID[] path and the `claude_audit_log` daily cost sum are tested only against a stubbed database, not real Postgres | Spec sections partly uncovered: `data_model.md#DS-31`; `ai_endpoints.md#POST /ai/check-daily-cost` | backlog_item_created — `BLG-QA-221` (filed in-cycle, PR #2022 review) |
| TSG-v9.12-02 | EPIC-04 | `settings_change_log` SQL is not exercised against real Postgres | Spec section partly uncovered: `data_model.md#DS-33` | backlog_item_created — `BLG-QA-226` (filed in-cycle, PR #2027 review) |
| TSG-v9.12-03 | EPIC-05 | ST-34–ST-38 have no automated scenarios | Spec/doc-only stories, no runtime behaviour | not_applicable — manual acceptance review is the correct method |

Every row has a disposition, so the Phase 4 exit criterion is met.

---

## §7 — System Status Confirmation

`docs/System_status_report.md`'s `## Sprint: 2026-10-12__release-v9.12` section was already present and accurate:
- All 6 merged EPICs appear under "Capabilities now live" with spec references.
- "Capabilities deferred or returned" correctly reads "None".
- ST-06, ST-28 and ST-34 (`ESC-EXEC-20261013-02`, `BLG-TECH-24`, `BLG-QA-223`) are noted against the EPIC-01, EPIC-04 and EPIC-05 rows, and ST-12's Pass with notes against EPIC-02.

**Corrections made this run:** routine only (STEP 6, BLG-GOV-170). The section's `**Status:**` line changed from `Sprint_Complete — pending verification` to `Verified_with_deviations — 2026-10-15`. The `**Last Updated:**` header was also updated, keeping the current entry plus 2 prior entries per CLAUDE.md §2.

---

## §9 — Sign-off Block

## Director of Quality Sign-off

- [x] Traceability complete (or gaps documented with rationale)
- [x] QA evidence reviewed and accepted
- [x] Deviation register reviewed; all P0/P1/P2 dispositions confirmed
- [x] Test coverage gaps actioned (backlog items created)
- [x] System status report confirmed accurate
- [x] Deferred execution blockers dispositioned

Signed off by: Sprint Execution Engine (agent-mediated, Director of Quality role — §5.3)
Date: 2026-10-15
Comments: Agent-mediated sign-off on explicit user direction (2026-10-15, §5.3), following the v9.8–v9.11 verification precedent. Pending human confirmation.
- Traceability: 48/48 items traced, 0 gaps.
- QA evidence: 0 Fail results across 6 EPICs. All signers use the recognised agent-mediated format.
- Deviations: 0 P0/P1/P2. Three P3-default `Pass_with_deviation` results (ST-06, closed, no remainder; ST-28 → `BLG-TECH-24`; ST-34 → `BLG-QA-223`). All are exempt from Known Deviations sync.
- Test coverage: 3 TSG rows, all dispositioned (2 existing backlog items, 1 not applicable).
- Observation: `BLG-QA-223` is P4 in `backlog.md` but P3 in `sprint_close.md`; left for the item owner.

## Product Owner Acceptance

- [x] Outstanding items confirmed in backlog
- [x] P1/P2 deviation acceptances confirmed (if any)
- [x] Deferred execution blocker outcomes acknowledged
- [x] Next cycle cleared to open

Accepted by: Sprint Execution Engine (agent-mediated, Product Owner role — §5.3)
Date: 2026-10-15
Comments: Agent-mediated acceptance on explicit user direction (2026-10-15, §5.3). Pending human confirmation.
- Outstanding items: none. All 8 delegations and 9 escalations are terminal, and all 45 follow-ups are in `backlog.md`.
- P1/P2 acceptances: none required.
- Deferred execution blockers: none.
- Next cycle cleared to open.
